Cardiovascular Effects of Atropine and Neostigmine in Man [PDF]
Dennis L. Fielder +3 more
openalex +1 more source
Resolution of Near-Work-Related Effects, Accommodation, and Binocular Vision Changes of 0.05% Atropine After 1 Year: Secondary Analysis of a Prospective Study. [PDF]
Pan W +11 more
europepmc +1 more source
Treatment Adherence in Myopia Progression Management: A Monocentric Retrospective Study on Rates and Determinants. [PDF]
Lembo A +4 more
europepmc +1 more source
Clinical efficacy of the atropine and pralidoxime treatment combined with hemoperfusion in patients with acute organophosphate pesticide poisoning. [PDF]
Lv F, Ding Y, Hu Q, Hu F.
europepmc +1 more source
Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activation. [PDF]
Jani NR +12 more
europepmc +1 more source
<i>In vitro</i> study of spontaneous motility and cholinergic responses in the human Hirschsprung's disease colon. [PDF]
Schulze F +4 more
europepmc +1 more source
Initial Dose of Intravenous Atropine for Patients With Symptomatic Bradycardia - A Scoping Review. [PDF]
Yokose M +16 more
europepmc +1 more source
Does 0.01% atropine have a place as a myopia control therapy? [PDF]
John R. Phillips +2 more
openalex +1 more source
Effectiveness of 0.01% atropine and orthokeratology for incipient myopia: a 1-year retrospective study. [PDF]
Sun X, Chu H, Zhang R, Han L, Yu J.
europepmc +1 more source

